loader2
Partner With Us NRI

Torrent Pharmaceuticals Ltd share Price Today

Company details

2,645.00
2,795.00
1,689.70
2,795.00
6M Return 27.00%
1Y Return 57.11%
Mkt Cap.(Cr) 89,865.61
Volume 1,077,403
Div Yield 1.06%
OI
-
OI Chg %
-
Volume 1,077,403

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Branded business continues to influence numbers…
About The Stock

    Incorporated in 1959, Torrent remains a key play in branded generics (~60% of sales) with strong India franchise and growing exports traction.

    • Revenues – India including CRAMs (59.8%), Brazil (8.3%), US (11.3%) and Germany (10.4%)
    • Torrent is the eighth largest domestic player and is ranked in top 10 for CVS, CNS, V&M, GI and anti-diabetes therapies in India
Q3FY23

    Growth in revenues boosted by branded generic markets i.e. India and Brazil.

    • Revenues grew 18.3% YoY to ₹ 2491 crore
    • EBITDA margins expanded ~361 bps YoY to 29.1%. EBITDA increased 35.1% to ₹ 724 crore
    • PAT increased 13.73% YoY to ₹ 283 crore

Click here for full recommendation

Research view on more stocks

Torrent Pharmaceuticals announced Q3FY24 results:

Financial Performance for Q3FY24:

  • Revenue: Rs 2,732 crore, indicating a 10% increase.
  • Gross Margin: 75%, maintaining a stable position in the market.
  • Operational EBITDA: Rs 869 crore, experiencing a 20% growth.
  • Exceptional Items: Gained net proceeds of Rs 88 crore from the sale of a US facility.
  • Net Profit After Tax (PAT): Rs 443 crore, marking a significant 52% surge.
  • Research & Development (R&D) Spend: Rs 127 crore, reaffirming the company's commitment to innovation.
  • Debt Equity Ratio: A ratio of 0.53, indicating a moderate level of debt in comparison to equity.
  • Debt Service Coverage Ratio: At 2.21, suggesting the company's ability to service its debt is well-managed.
  • Interest Service Coverage Ratio: Standing at 9.08, showing a strong ability to meet interest expenses.
  • Net Profit Margin: The net profit margin stood at 16%, representing the profitability from the revenue earned.

Country-wise Performance for Q3FY24:

  • India: Revenues reached Rs 1,415 crore, up by 12%, outperforming the market in focus therapies.
  • Brazil: Reported revenues of Rs 312 crore, growing by 26%, with constant currency revenues up by 17%.
  • Germany: Achieved revenues of Rs 270 crore, increasing by 12%, with constant currency revenues rising by 6% due to tender wins.
  • United States: US business revenues saw a slight decrease of 6% to Rs 274 crore, with constant currency revenues down by 7%, affected by a lack of new product launches.

 

Result PDF

View Other Company Results

Torrent Pharmaceuticals Ltd shares SWOT Analysis

Strengths (16)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Company with high TTM EPS Growth

Weakness (1)

  • MFs decreased their shareholding last quarter

Opportunity (1)

  • High Volume, High Gain

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 2,751.8
R2 2,848.4
R3 2,901.8
Pivot

2,698.42

S1 2,601.8
S2 2,548.4
S3 2,451.8
EMA SMA
2,650.4
2,620.4
2,530.4
2,339.5
2,654.0
2,619.5
2,580.9
2,285.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SEB ASIENFOND EX JAPAN Block Purchase 2024-03-07 2691.2 63294 NSE
SEB FUND 3 SEB PENSION FUND Block Sell 2024-03-07 2691.2 63294 NSE
SOCIETE GENERALE Block Purchase 2024-01-25 2507.05 474629 BSE
Name Category Shares
TORRENT INVESTMENTS PRIVATE LIMITED PROMOTER 71.25%

OUR RESEARCH VIEW

Investment recommendation
Branded business continues to influence numbers…
Call Date
27 Jan 2023
Entry Price 1,557.00
Target Price 1,720.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Torrent Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Torrent Pharmaceuticals Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 2,655.25 1,466.05 1,478.65 4,255.25 1,058.50
% Change 1.63 -1.39 -0.52 3.22 -1.63
Mcap Cr 89,865.61 351,754.51 119,381.32 112,963.70 106,509.87
Revenue TTM Cr 9,620.15 43,885.68 15,790.60 7,767.51 17,237.40
Net Profit TTM Cr 1,245.23 8,560.84 2,513.47 1,823.38 1,997.30
PE TTM 56.35 35.16 28.03 70.58 27.63
1 Year Return 57.11 53.97 57.64 25.78 110.04
ROCE 19.48 16.79 14.76 19.30 16.25
ROE 20.50 16.46 10.66 14.89 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 6,198.07 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 35,090.66 -22,978.04
LAST 3M 106,793.94 -34,010.07
LAST 6M 169,541.16 45,373.47
LAST 12M 268,709.66 125,819.23
Torrent Pharmaceuticals Limited - Outcome of Board Meeting

May 27, 2024 l NSE Announcement

Board of Torrent Pharmaceuticals recommends final dividend

May 25, 2024 l BSE Announcement

NSE Board Meetings Forthcomming

May 24, 2024 l NSE Board Meetings Forthcomming

Date Action Type Ratio
Feb 12, 2024 Dividend 440
Jun 23, 2023 Dividend 160
Feb 03, 2023 Dividend 280

Torrent Pharmaceuticals Ltd Information

Stock PE (TTM)
56.35
Promoter Holding
71.25%
Book Value
202.5887
ROCE
19.48%
ROE
20.5%
Registered Address

Torrent House, Off Ashram Road, Ahmedabad, Gujarat, 380009

Tel : 91-79-26599000
Email : investorservices:torrentpharma.com
Website : http://www.torrentpharma.com
Registrar

Karvy Computershare Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 500420
NSE Code : TORNTPHARM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE685A01028

FAQ’s on Torrent Pharmaceuticals Ltd Shares

You can buy Torrent Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Torrent Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 27, 2024 03:55 PM the closing price of Torrent Pharmaceuticals Ltd was Rs.2,655.25.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 27, 2024 03:55 PM, the market cap of Torrent Pharmaceuticals Ltd stood at Rs. 89,865.61.

The latest PE ratio of Torrent Pharmaceuticals Ltd as of May 27, 2024 03:55 PM is 56.35

The latest PB ratio of Torrent Pharmaceuticals Ltd as of May 27, 2024 03:55 PM is 0.08

The 52-week high of Torrent Pharmaceuticals Ltd share price is Rs. 2,795.00 while the 52-week low is Rs. 1,689.70

According to analyst recommendations, Torrent Pharmaceuticals Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app